Top compounds associated with response to TTYH3


Feature Type Standardized
Nominal ANOVA
mRNA cimetidine CTRPv2 pan-cancer AAC 0.2 0.01
mRNA FSC231 CTRPv2 pan-cancer AAC 0.21 0.02
mRNA pac-1 CTRPv2 pan-cancer AAC 0.096 0.02
mRNA linifanib GDSC1000 pan-cancer AAC 0.089 0.02
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.098 0.02
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.081 0.02
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.02
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.21 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.02
mRNA Merck60 CTRPv2 pan-cancer AAC 0.077 0.02
Download CSV